“Early Molecular Response to Imatinib Mesylate Predicts Long-Term Outcomes in CML Patients in A Postgraduate Research Institute — A Single Center Study”. 2024. The Planet 7 (01): 255-66. https://bdjournals.org/index.php/planet/article/view/427.